维普中文期刊产品整合服务
68篇 您的检索式:作者名="Tanda ML"
    题名 作者 年代 出处 被引量
1Prevalence and natural history of Graves′ orbitopathy in the XXI century显示文摘Piantanida E Tanda ML Lai A 2013J Endocrinol Invest2013,36,6:1
2An update on medical management of Graves'ophthalmopathy显示文摘Bartalena L Marcocci C Tanda ML 2005J Endocrinol Invest2005,28,5:1
3Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of prospective, single-blind, randomized study 显示文摘Marcocci C Bartalena L Tanda ML 2001J Clin Endocrinol Metab2001,86,8:1
4Graves ophthalmopathy and 131I therapy显示文摘Marcocci C Bartalena L Tanda ML 1999Q J Nucl Med1999,43,4:1
5Comparison of the effectiveness and tolerability of intravenous or oral glueoeortieoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy : results of a prospective, single-blind, randomized study显示文摘Mareocei C Bartalena L Tanda ML 2001J Clin Endocrinol Metab2001,86,8:1
6Efficacy and safety of orbital radiotherapy for graves'orbitopathy显示文摘Tanda ML Bartalena L 0,,11:1
7Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves′ ophthalmopathy: results of a prospective, single-blind, ran- domized study显示文摘Marcocci C Bartalena L Tanda ML 2001J Clin Endocrinol Metab2001,86,8:1
8Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective,single-blind, randomized study显示文摘 Bartalena L Tanda ML 2001J Clin Endocrinol Metab2001,86,8:1
9Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study显示文摘Marcocci C Bartalena L Tanda ML 2001J Clin Endocrinol Metab2001,86,8:1
10Graves’oph-thalmopathy and 131I therapy显示文摘Marcocci C Bartalena L Tanda ML 1999Q J Nucl Med1999,43,4:1
11Orbital radiotherapy for Graves' ophthalmopathy 显示文摘Bartalena L Marcoeei C Tanda ML 2002Thyroid2002,12,:1
12Cigarette smoking and treatment outcomes in Graves; ophthalmopathy显示文摘Bartalena L Marcocci C Tanda ML 1998Ann Intern Med1998,129,8:1
13Diagnosis and man- agement of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidolo- gists显示文摘Tanda ML Piantanida E Lai A 2008Clin Endocrinol(Oxf)2008,69,5:1
14Cigarette smoking and treatment outcomes in Graves ophthalmopathy显示文摘Bartalena L Marcocci C Tanda ML 1998Ann In- tern Med1998,129,8:1
15Amiodarone-indnced thyrotoxicosis: something new to refine the initial diagnosis? 显示文摘Tanda ML Bogazzi F Martino E 2008Eur J Endoerineol2008,159,4:1
16Efficacy and safety of orbital radiotherapy for graves'orbitopathy显示文摘Tanda ML Bartalena L 2012J Clin Endocrinol Metab2012,97,11:1
17An update on medical management of Graves ophthalmopathy显示文摘Bartalena L Marcocci C Tanda ML 2005J Endocrinol Invest2005,28,5:1
18Efficacy and safety of orbital radiotherapy for graves' orbitopathy 显示文摘Tanda ML BartMena L 2012J Clin Endocrinol Metab2012,97,11:1
19Clinical practice Graves' ophthalmopathy显示文摘Bartalena L Tanda ML 0,,:1
20Clinical practice of Graves'ophthalmopathy显示文摘Bartalena L Tanda ML 2009N Engl J Med2009,360,10:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费